In recent years, the monoclonal antibody market around the globe has witnessed substantial growth, and the CAGR of market scale during 1997-2011 has reached 44% approximately. It is predicted that the global monoclonal antibody market scale will reach USD78 billion in 2012. Meanwhile, monoclonal antibody is also a key major source of blockbuster drugs. In 2011, the sales of six monoclonal antibody agents as Infliximab (Johnson & Johnson), Etanercept (Amgen), Bevacizumab (Roche), Rituximab (Roche
View Full Report: Global and China Monoclonal Antibody Industry Report, 2013
Contact: sales@researchmoz.us for further information.
Browse All Reports: Latest Market Research Reports
Browse All Reports: Countrywide Market Research Reports
Browse All Reports: Transparency Market Research Reports
Browse All Reports: Technavio Market Research Reports
Browse All Reports: Winter Green Market Research Reports
Browse All Reports: QY Market Research Reports
Browse All Reports: GBI Market Research Reports
Browse All Reports: Select Biosciences Market Research Reports
No comments:
Post a Comment